Colorectal Cancer Treatment Market size was over USD 19.27 billion in 2023 and is expected to exceed USD 32.9 billion by the end of 2036, witnessing over 4.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of colorectal cancer treatment is evaluated at USD 19.92 billion.
The rising prevalence of colorectal cancer globally, along with the growth in efficient treatment options, are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing advancement in diagnostic methods on a global level. As per American Cancer Society, in U.S, 101,420 new cases of colon cancer and 44,180 new cases of rectal cancer, were registered in 2019.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
4.2% |
|
Base Year Market Size (2023) |
USD 19.27 billion |
|
Forecast Year Market Size (2036) |
USD 32.9 billion |
|
Regional Scope |
|
The market is segmented on the basis of treatment type into surgery, chemotherapy, immunotherapy, radiotherapy, targeted therapy, ablation and others, out of which, the targeted therapy segment is anticipated to grab the largest share by the end of 2021 on account of technological advancements and better efficiency of targeted therapy than other therapies, for the treatment of colorectal cancer. Moreover, there is a large availability of prominent targeted therapies, which is also projected to contribute to the growth of the segment during the forecast period.
On the basis of end-user, the general medical & surgical hospitals segment in the global colorectal cancer treatment market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that general medical & surgical hospitals possess well-developed healthcare infrastructure for the diagnosis and treatment of colorectal cancer.
Our in-depth analysis of the global market includes the following segments:
|
By Treatment Type |
|
|
By End-User |
|
Geographically, the colorectal cancer treatment market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific industry is set to dominate majority revenue share by 2036, owing to increasing awareness about colorectal cancer and need to develop innovative cancer treatment solutions in the region.
Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, owing to the high prevalence of colorectal cancer, accompanied by the presence of leading healthcare service providers in the region. Along with this, North America also has an increasingly ageing population, which is also expected to contribute to the market growth in the region. Alternatively, the market in Europe is also anticipated to occupy a significant share in the market on account of the rise in colorectal cancer diagnostic tests and a large presence of individuals suffering from colorectal cancer in the region. As per an epidemiologic study from the European Union, in 2018, colorectal cancer was ranked second among the deaths from cancer in Europe, with 98000 deaths in men and 79,400 deaths in women.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?